OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) Shares Fall After Disappointing Trial Results
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) reported disappointing Phase 3 AFFINITY trial results on Tuesday evening causing their shares to fall significantly this morning. While it’s impossible…
